corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

All items in the Healthy Skepticism Library

All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 62 of 206 pages ‹ First  < 60 61 62 63 64 >  Last ›

HSL12779
Lazarus D.
Ads spur urge for drugs
The LA Times 2008 Feb 6
http://www.latimes.com/business/la-fi-lazarus6feb06,1,4632382.column?track=rss&ctrack=1&cset=true

HSL12731
Jutel A, Menkes DB.
Soft Targets: Nurses and the Pharmaceutical Industry
PLoS Medicine 2008 Feb 5;5:(2):5
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050005

HSL12736
McKee S.
Government encourages NHS/industry partnerships
PharmaTimes 2008 Feb 5
http://www.pharmatimes.com/uknews/article.aspx?id=12786&src=EWorldNews

HSL12742
Loftus P.
US Prescriptions For Vytorin, Zetia Rebounded Last Week -Firm
CNN Money.com 2008 Feb 5
http://money.cnn.com/news/newsfeeds/articles/djf500/200802051642DOWJONESDJONLINE000601_FORTUNE5.htm

HSL13134
Taubes G.
What's cholesterol got to do with it.
International Herald Tribune 2008 Feb 5
http://www.iht.com/articles/2008/02/05/opinion/edtaubes.php

HSL13564
Barber C
Comfortably Numb: How Psychiatry Is Medicating a Nation
: Pantheon Books 2008 Feb 05
http://www.randomhouse.com/pantheon/catalog/display.pperl?isbn=9780375423994

HSL12715
Woodhead M.
How much are you worth?
6minutes.com.au 2008 Feb 4
http://www.6minutes.com.au/dirplus/images/6minutes/newspluspharma/4_02_2008.pdf

HSL12716
Second Guessing Continues For Merck, Schering
CNN Money.com 2008 Feb 4
http://money.cnn.com/news/newsfeeds/articles/newstex/IBD-0001-22724219.htm

HSL12717
Grogan K.
AstraZeneca excited by potential of emerging markets
PharmaTimes 2008 Feb 4
http://www.pharmatimes.com/WorldNews/article.aspx?id=12776

HSL12718
Jordan GE, Todd S.
In wake of Vytorin study, some heart doctors reassess LDL factor
The Star Ledger 2008 Feb 4
http://www.nj.com/business/index.ssf/2008/02/in_wake_of_vytorin_study_heart.html

HSL12737
Marketing Overdose Campaign Films
PharmaLive 2008 Feb 4
http://pharmalive.com/news/index.cfm?articleID=511716&categoryid=9&newsletter=1

HSL12738
Manhattan Research Ranks the Top Pharmaceutical Branded Websites by Rx Request Rates
PharmaLive 2008 Feb 4
http://pharmalive.com/news/index.cfm?articleID=511115&categoryid=9&newsletter=1

HSL13061
Freking K.
Brand-Name Drugs Continue Brisk Increase
Newsday 2008 Feb 4
http://www.newsday.com/news/politics/wire/sns-ap-drug-prices-aarp,0,6193058.story

HSL15007
Gilmore I.
Build bridges with the drugs industry—but keep patients in mind
BMJ. 2008 Feb 4;338:
http://www.bmj.com/cgi/content/extract/338/feb04_1/b439

HSL12719
Schmit J.
FDA caution, 'research drought' cuts drug approvals
USA Today 2008 Feb 3
http://www.usatoday.com/money/industries/health/2008-02-03-fda-drugs_N.htm

HSL12842
Edelman S, Klein M.
Medicaid Kids in Psych-Rx $urge
The New Post 2008 Feb 3
http://www.nypost.com/seven/02032008/news/regionalnews/medicaid_kids_in_psych_rx_urge_702469.htm

HSL12680
Coaching to support patients in making decisions
BMJ 2008 Feb 2;336:(7638):228
http://www.bmj.com/cgi/content/extract/336/7638/228?etoc

HSL12681
Drug company payments: Speakers should declare funding
BMJ 2008 Feb 2;336:(7638):234
http://www.bmj.com/cgi/content/extract/336/7638/234?etoc

HSL12682
Stone JA.
Testosterone supplementation: An unfortunate juxtaposition
BMJ 2008 Feb 2;336:(7638):234
http://www.bmj.com/cgi/content/extract/336/7638/234-c?etoc

HSL12683
Hopkins Tanne J.
NIH needs to raise oversight of conflicts of interest among researchers, report says
BMJ 2008 Feb 2;336:(7638):235
http://www.bmj.com/cgi/content/extract/336/7638/235?etoc

HSL12684
Hopkins Tanne J.
US Institute of Medicine recommends new body to assess what works in health care
BMJ 2008 Feb 2;336:(7638):236
http://www.bmj.com/cgi/content/extract/336/7638/236?etoc

HSL12685
Roehr B.
Pressure mounts to cut US spending on health care
BMJ 2008 Feb 2;336:(7638):236-7
http://www.bmj.com/cgi/content/extract/336/7638/236-a?etoc

HSL12686
Kmietowicz Z.
Double blind peer reviews are fairer and more objective, say academics
BMJ 2008 Feb 2;336:(7638):238
http://www.bmj.com/cgi/content/extract/336/7638/241?etoc

HSL12687
Hawkes N.
Body Politic: How do we get the measure of patient care?
BMJ 2008 Feb 2;336:(7638):249
http://www.bmj.com/cgi/content/extract/336/7638/249?etoc

HSL12688
Hughes S.
Open Letter: European regulatory agencies should employ full time statisticians
BMJ 2008 Feb 2;336:(7638):250
http://www.bmj.com/cgi/content/extract/336/7638/250?etoc

HSL12689
Claxton K, Briggs A, Buxton MJ, Culyer AJ, McCabe C, Walker S, Sculpher MJ.
Value based pricing for NHS drugs: an opportunity not to be missed?
BMJ 2008 Feb 2;336:(7638):251
http://www.bmj.com/cgi/content/extract/336/7638/251?etoc

HSL12690
Degos L, Romaneix F, Michel P, Bacou J.
Looking to Europe: Can France keep its patients happy?
BMJ 2008 Feb 2;336:(7638):254-7
http://www.bmj.com/cgi/content/extract/336/7638/254?etoc

HSL12709
Parnell S.
PBS cost recovery on agenda
The Australian 2008 Feb 2
http://www.theaustralian.news.com.au/story/0,25197,23139787-23289,00.html

HSL12714
Parnell S.
PBS cost recovery revisited
The Australian 2008 Feb 2
http://www.theaustralian.news.com.au/story/0,25197,23139787-23289,00.html

HSL12843
Begley S.
Happiness: Enough Already: The push for ever-greater well-being is facing a backlash, fueled by research on the value of sadness.
Newsweek 2008 Feb 2
http://www.newsweek.com/id/107569/output/print

HSL12644
Treerutkuarkul A.
Novartis offer halts CL plan for imatinib: Free for all leukaemia patients in state care
The Bangkok Post 2008 Feb 1
http://www.bangkokpost.com/News/01Feb2008_news10.php

HSL12649
Won Tesoriero H
Federal Grand Jury Probes Merck's Handling of Vioxx
The Wall Street Journal 2008 Feb 1
http://online.wsj.com/article/SB120182583816633697.html?mod=yahoo_hs&ru=yahoo

HSL12650
Hensley S.
Federal Grand Jury Probes Biovail Over Cardizem LA
The Wall Street Journal 2008 Feb 1
http://blogs.wsj.com/health/2008/02/01/federal-grand-jury-probes-biovail-over-cardizem-la/

HSL12655
FDA Issues Public Health Advisory on Chantix: Agency requests that manufacturer add new safety warnings for smoking cessation drug
FDA News 2008 Feb 1
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01788.html

HSL12657
Biovail Receives Letter Related to 2003 Cardizem LA Launch Activities from U.S. Attorney's Office
PharmaLive 2008 Feb 1
http://pharmalive.com/news/index.cfm?articleID=510755&categoryid=9&newsletter=1

HSL12658
Consumers Union to FDA: Put 800-Number, Web Site on TV Drug Ads
Therapeutics Daily 2008 Feb 1
http://www.therapeuticsdaily.com/news/article.cfm?contentValue=1705645&contentType=sentryarticle&channelID=33

HSL12693
Lessard D.
Les antipsychotiques explosent chez les aînés et les démunis
cyberpresse.ca 2008 Feb 1
http://www.cyberpresse.ca/article/20080201/CPACTUALITES/802010596

HSL12700
Zyprexa woes keep piling up for Eli Lilly
News Observer 2008 Feb 1
http://www.newsobserver.com/business/story/916886.html

HSL12706
Hoffman JM, Shah ND, Vermeulen LC, Doloresco F, Grim P, Hunkler RJ, Hontz KM, Schumock GT.
Projecting future drug expenditures--2008.
Am J Health Syst Pharm 2008 Feb 1;65:(3):234-53
http://www.ajhp.org/cgi/content/full/65/3/234

HSL12722
Generics are being held up by regulatory agencys, claims EGA
PharmaTimes 2008 Feb 1
http://www.pharmatimes.com/worldnews/article.aspx?id=12769&src=EWorldNews

HSL12734
Pharmacovigilance in Europe and patient safety: no to deregulation
Medicines in Europe Forum, Health Action International Europe and International Society of Drug Bulletins 2008 Feb 1
http://www.isdbweb.org/pag/documents/PR_ConsultPharmacoVigJan08_En.pdf

HSL12750
Bate A, Lindquist M, Edwards IR.
The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database.
Fundam Clin Pharmacol 2008 Feb 1;
http://www.ncbi.nlm.nih.gov/pubmed/18248442

HSL12776
Wipond R.
CanWest Global Attacks Drug Ad Laws
Focus 2008 Feb 1
http://robwipond.com/?p=50

HSL12884
UK Department of Health
Best practice guidance for joint working between the NHS and the pharmaceutical industry
: UK Department of Health 2008 Feb 1
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_082370

HSL13166
Roy P, Buch AN, Javaid A, Okabe T, Raya V, Pinto Slottow TL, Steinberg DH, Smith K, Xue Z, Gevorkian N, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.
Impact of 'off-label' utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
Am J Cardiol 2008 Feb 1;101:(3):293-9
http://linkinghub.elsevier.com/retrieve/pii/S0002-9149(07)01903-0

HSL13167
Ting HH, Roe MT, Gersh BJ, Spertus JA, Rumsfeld JS, Ou FS, Kao J, Long KH, Holmes DR Jr, Peterson ED; National Cardiovascular Data Registry (NCDR).
Factors associated with off-label use of drug-eluting stents in patients with ST-elevation myocardial infarction.
Am J Cardiol 2008 Feb 1;101:(3):286-92
http://linkinghub.elsevier.com/retrieve/pii/S0002-9149(07)01901-7

HSL12581
Saginur M, Graham ID, Forster AJ, Boucher M, Wells GA.
The uptake of technologies designed to influence medication safety in Canadian hospitals.
J Eval Clin Pract 2008 Feb;14:(1):27-35
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2007.00780.x

HSL12582
Buurma H, Bouvy ML, De Smet PA, Floor-Schreudering A, Leufkens HG, Egberts AC.
Prevalence and determinants of pharmacy shopping behaviour.
J Clin Pharm Ther 2008 Feb;33:(1):17-23
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2710.2008.00878.x

HSL12583
Mason A.
New medicines in primary care: a review of influences on general practitioner prescribing.
J Clin Pharm Ther 2008 Feb;33:(1):1-10
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2710.2008.00875.x

HSL12591
Siracuse MV, Vuchetich PJ.
Impact of Medicaid Prior Authorization Requirement for COX-2 Inhibitor Drugs in Nebraska.
Health Serv Res 2008 Feb;43:(1):
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1475-6773.2007.00766.x

HSL12692
Cassels A.
Media mum on bad news drugs
Common Ground 2008 Feb
http://commonground.ca/iss/199/cg199_cassels.shtml

HSL12697
Is the Tipping Point Toast?
Fast Company.com 2008 Feb
http://www.fastcompany.com/magazine/122/is-the-tipping-point-toast.html

HSL12710
Pharmacovigilance in Europe and patient safety: no to deregulation
HAI 2008 Feb
www.haiweb.org/15022008/PR_ConsultPharmacoVigJan08_En.pdf

HSL12724
Barker E.
A World Without Men
Whole Life Times 2008 Feb
http://wholelifetimes.com/2008/02/healthyliving0802.html

HSL12725
Pearce N.
Corporate influences on epidemiology.
Int J Epidemiol 2008 Feb;37:(1):46-53
http://www.ncbi.nlm.nih.gov/pubmed/18245050?dopt=Abstract

HSL12726
Haas J.
Commentary: Epidemiology and the pharmaceutical industry: an inside perspective.
Int J Epidemiol 2008 Feb;37:(1):53-5
http://ije.oxfordjournals.org/cgi/content/extract/37/1/53

HSL12727
White A, Robinson N, Egger P, Stender M, Davis K, Weil J, Bowlin S.
Commentary: Collaboration between industry-based and academic epidemiologists.
Int J Epidemiol 2008 Feb;37:(1):56-7
http://ije.oxfordjournals.org/cgi/content/extract/37/1/56

HSL12728
Greenland S.
Commentary: addressing corporate influence through ethical guidelines.
Int J Epidemiol 2008 Feb;37:(1):57-9
http://ije.oxfordjournals.org/cgi/content/extract/37/1/57

HSL12729
Phillips CV.
Commentary: Lack of scientific influences on epidemiology.
Int J Epidemiol 2008 Feb;37:(1):59-64
http://ije.oxfordjournals.org/cgi/content/extract/37/1/59

HSL12730
Pearce N.
Response: The distribution and determinants of epidemiologic research.
Int J Epidemiol 2008 Feb;37:(1):65-8
http://ije.oxfordjournals.org/cgi/content/extract/37/1/65

HSL12787
Millard WB.
Dispatch from the pharmasphere: an industry's fault lines on display.
Ann Emerg Med 2008 Feb;51:(2):175-80
http://www.ncbi.nlm.nih.gov/pubmed/18217227?dopt=Abstract

HSL12839
FDA
Guidance for Industry: Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices
: FDA 2008 Feb
http://www.fda.gov/oc/op/goodreprint.html

HSL12848
Kaufman SR.
Bias and sponsored research.
Ophthalmology 2008 Feb;115:(2):412-3
http://linkinghub.elsevier.com/retrieve/pii/S0161-6420(07)00852-4

HSL12872
Siekmeier R, Lütz J, Wetzel D.
[Are test systems for diagnostics of infectious diseases safe? Experiences of the BfArM based on all notifications received until end of 2005]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2008 Feb;51:(2):221-34
http://www.springerlink.com/content/y8683g7084571486/

HSL12909
Schipper I, Weyzig F
Ethics for Drug Testing in Low and Middle Income Countries: Considerations for European Market Authorisation
Amsterdam: Stichting Onderzoek Multinationale Ondernemingen (Centre for Research on Multinational Corporations) 2008 Feb
http://www.somo.nl/html/paginas/pdf/Ethics_for_Drug_Testing_feb08_EN.pdf

HSL12948
Association of American Medical Colleges (AAMC) / Association of American Universities (AAU)
Protecting Patients, Preserving Integrity, Advancing Health: Accelerating the Implementation of COI policies in Human Subjects Research
: Association of American Medical Colleges (AAMC) / Association of American Universities (AAU) 2008 Feb
https://services.aamc.org/Publications/showfile.cfm?file=version107.pdf&prd_id=220&prv_id=268&pdf_id=107

HSL12949
Herxheimer A, Sanz E.
Social, cultural and ethical aspects of drug use—changes over 40 years: a personal look back
European Journal of Clinical Pharmacology 2008 Feb;64:(2):107-114
http://www.springerlink.com/content/u2rn52n6x15x71h6/fulltext.html

HSL13034
Hayden EC.
Battle over eye medicine gives drugmaker a dose of reality
Nat Med 2008 Feb;14:(2):108
http://www.nature.com/doifinder/10.1038/nm0208-108

HSL13035
Hughes V.
Europe pledges billions to solve its drug development woes.
Nat Med 2008 Feb;14:(2):107
http://www.nature.com/doifinder/10.1038/nm0208-107

HSL13380
[No authors listed]
ADA advertising standards.
J Am Dent Assoc. 2008 Feb;139:(2):204-5

HSL13458
O'Donovan O, Glavanis-Grantham K. (Eds)
Power, Politics and Pharmaceuticals: Drug Regulation in Ireland in the Global Context
: Cork University Press 2008
http://www.corkuniversitypress.com/epages/corkuniversitypress.storefront

HSL13506
Gibson BR, Suh R, Tilson H.
The US drug safety system: role of the pharmaceutical industry.
Pharmacoepidemiol Drug Saf. 2008 Feb;17:(2):110-4
http://www3.interscience.wiley.com/cgi-bin/abstract/115807412/ABSTRACT?CRETRY=1&SRETRY=0

HSL13543
Kahn M, Gastrow M.
Pharmacologically active: clinical trials and the pharmaceutical industry.
S Afr Med J 2008 Feb;98:(2):114-6

HSL13682
Bruce S.
Cosmeceuticals for the attenuation of extrinsic and intrinsic dermal aging.
J Drugs Dermatol 2008 Feb;7:(2):
http://www.ncbi.nlm.nih.gov/pubmed/18404867

HSL13685
Shoenfeld Y.
[Doctors as naive (innocent) drug advertisers].
Harefuah 2008 Feb;147:(2):98-9
http://www.ncbi.nlm.nih.gov/pubmed/18357661

HSL13750
Trabert G.
[The development of the public health system between an increasing market orientation (commercialisation) and social responsibility].
Zentralbl Chir 2008 Feb;133:(1):39-45
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2008-1004667

HSL13801
Juni S, Gross JS.
Emotional and persuasive perception of fonts.
Percept Mot Skills 2008 Feb;106:(1):35-42
http://www.ncbi.nlm.nih.gov/pubmed/18459353

HSL13838
Berg TL.
The creation of the medical consumer.
S D Med 2008 Feb;61:(2):42
http://www.ncbi.nlm.nih.gov/pubmed/18432148

HSL14210
Demortain D.
From drug crises to regulatory change: The mediation of expertise
Health, Risk & Society 2008 Feb;10:(1):37-51
http://www.tandf.co.uk/journals/journal.asp?issn=1369-8575&linktype=9

HSL16107
Barnard J, Lai R, Robson A
Increasing Transparency in Pharmaceutical Marketing Communications: the new code from the European Federation of Pharmaceutical Industries and Associations (EFPIA)
: KeywordPharma 2008 Feb
http://www.keywordpharma.com/selection5/

HSL12640
Fox M.
U.S. researcher admits to leaking drug data
The Guardian 2008 Jan 31
http://www.guardian.co.uk/feedarticle?id=7269595

HSL12641
Lilly may settle over anti-psychotic Zyprexa
CNN Money.com 2008 Jan 31
http://money.cnn.com/2008/01/31/news/companies/lilly_zyprexa.ap/index.htm?source=yahoo_quote

HSL12642
Imclone Swings to Loss on Legal Charge
Yahoo.com 2008 Jan 31
http://biz.yahoo.com/ap/080131/earns_imclone.html?.v=1

HSL12643
Rubenstein S.
When Drug Trials Go Wrong, Patients Have Little Recourse
The Wall Street Journal 2008 Jan 31
http://online.wsj.com/article/SB120173515260330205.html

HSL12647
Murphy T.
Shareholders Sue Lilly Over Zyprexa Woes
Yahoo Finance 2008 Jan 31
http://biz.yahoo.com/ap/080131/zyprexa_lawsuit.html?.v=2

HSL12648
Berenson A.
Lilly Considers $1 Billion Fine to Settle Case
The New York Times 2008 Jan 31
http://www.nytimes.com/2008/01/31/business/31drug.html?_r=1&oref=slogin

HSL12654
FDA Alerts Health Care Providers to Risk of Suicidal Thoughts and Behavior with Antiepileptic Medications
FDA 2008 Jan 31
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01786.html

HSL12694
Johnson A, Carreyrou J.
Lilly Is in Talks to Settle Zyprexa Allegations
The Wall Street Journal 2008 Jan 31
http://online.wsj.com/article/SB120174903737930987.html

HSL12696
Ward G.
Vanderbilt bans most gifts from drug firms
Tennessean.com 2008 Jan 31
http://www.fairviewobserver.com/apps/pbcs.dll/article?AID=/20080131/BUSINESS01/801310366/1321/MTCN06

HSL12698
Bansal P.
Merck probed over Vioxx marketing: report
Reuters.com 2008 Jan 31
http://www.reuters.com/article/ousiv/idUSN3137171220080201

HSL12699
Lawler B.
Who Let the Docs Out?
The Motley Fool 2008 Jan 31
http://www.fool.com/investing/dividends-income/2008/01/31/who-let-the-docs-out.aspx

HSL12739
Schuettler D.
Thailand scraps patent override on Novartis drug
Reuters.com 2008 Jan 31
http://www.reuters.com/article/africaCrisis/idUSBKK24285

HSL12784
Boscoe M, Lippman A, Reynolds A, Rochon Ford A
Letter to the editor re: disinformation about HPV vaccine
: The Canadian Women's Health Network 2008 Jan 31
http://www.cwhn.ca/resources/pub/globe_letter_jan08.htm

HSL12623
Vastag B.
Reviewer leaked Avandia study to drug firm: GlaxoSmithKline told early of diabetes blockbuster's links to heart attacks.
naturenews 2008 Jan 30
http://www.nature.com/news/2008/080130/full/451509a.html

HSL12625
Berenson A.
Lilly in Settlement Talks With U.S.
The New York Times 2008 Jan 30
http://www.nytimes.com/2008/01/30/business/30cnd-drug.html?ref=business

HSL12627
Metherell M.
Drugs no longer only remedy as GPs cut scripts
The Sydney Morning Herald 2008 Jan 30
http://www.smh.com.au/news/national/drugs-no-longer-only-remedy-as-gps-cut-scripts/2008/01/29/1201369135245.html

HSL12629
Cresswell A.
Doctors rushing patients for tests
The Australian 2008 Jan 30
http://www.theaustralian.news.com.au/story/0,25197,23130168-23289,00.html

HSL12630
Goldstein J.
What’s Buried In Merck’s Earnings
The Wall Street Journal 2008 Jan 30
http://blogs.wsj.com/health/2008/01/30/whats-buried-in-mercks-earnings/?mod=yahoo_hs

HSL12631
Koroneos G.
Vytorin Scripts Plummet
PharmExec.com 2008 Jan 30
http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=487084

HSL12633
Won TesorIiero H.
Trouble Brews Over Merck Product
The Wall Street Journal 2008 Jan 30
http://online.wsj.com/article/SB120165519331327133.html?mod=googlenews_wsj

Page 62 of 206 pages ‹ First  < 60 61 62 63 64 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.